Clinical Trials

Overview

About this study

Medical education and continuous professional development (CPD) are effective when it demonstrates translation of learning to clinical practice. The severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has changed the landscape of CPD as in-person meetings and the associated social networking that occurs through these interactions has now largely disappeared. Limited data exists to guide the integration of social learning into online education; this study seeks to increase understanding of the impact of social learning on online education. The theory of planned behavior (TPB) will be used as a framework to evaluate impact.

• AIM 1: Identify differences in knowledge acquisition, attitudes, values, beliefs, and intent to utilize pharmacogenomics (PGx) in clinical practice between two groups: one who has participated in an online PGx education program only and one who has participated in an online PGx education program and participated in small group discussion about the content led by a subject matter expert (PGx pharmacist). Small group discussion allows for learning from both experts and peers in a collective group that supports social interaction. It is hypothesized that those who participate in the small group discussion will score more positively in relation to knowledge, attitudes, values, and beliefs than those who participate in the online education only.
•  AIM 2: Gain a deeper understanding of the practice impact of incorporating social learning theory constructs into online CPD education. This will be assessed by measuring the number of PGx tests and consults ordered after the CPD education. Further, a survey will measure self-reported use of PGx in making care decisions. It is hypothesized that those who participate in the small group discussion will be more likely to use PGx principles in the clinical environment and incorporate PGx information as a part of regular clinical practice. To achieve these aims, a randomized prospective study of physicians, nurse practitioners, and physician assistants who practice at throughout the Mayo Clinic enterprise will be conducted. Data from this study will help identify the impact of social learning theory on supporting implementation of PGx learning into practice and guide future endeavors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information